NCT01225224View on ClinicalTrials.gov

Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 18, 2009

Primary Completion Date

March 10, 2010

Study Completion Date

March 10, 2010

Conditions
Pharmacokinetics of ASP015KHealthy Volunteer
Interventions
DRUG

peficitinib

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY